Improvement in HRQoL With Dupilumab in Patients With Moderate to Severe Asthma With Comorbid Chronic Rhinosinusitis With/Without Nasal Polyps
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of asthma and allergy
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study
J Asthma Allergy 2022 Sep 01;15(xx)767-773, C Hopkins, KM Buchheit, E Heffler, NA Cohen, H Olze, AH Khan, J Msihid, S Siddiqui, S Nash, JA Jacob-Nara, PJ Rowe, Y DenizFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.